Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Atherosclerosis|December 1, 1990
Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosingD B Hunninghake, M J Mellies, A C Goldberg, et al.Metabolism: Clinical and Experimental|February 1, 1980
Nutrient intake: relationships with lipids and lipoproteins in 6--19-year-old children--the Princeton School District studyJ A Morrison, R Larsen, L Glatfelter, et al.Pediatrics|April 1, 1980
Interrelationships between nutrient intake and plasma lipids and lipoproteins in schoolchildren aged 6 to 19: the Princeton School District StudyJ A Morrison, R Larsen, L Glatfelter, et al.Atherosclerosis|November 1, 1990
Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response studyD B Hunninghake, R H Knopp, G Schonfeld, et al.Clinical Therapeutics|January 1, 1989
Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US studyA C Goldberg, G Schonfeld, E B Feldman, et al.Circulation|December 8, 1998
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care InvestigatorsR B Goldberg, M J Mellies, F M Sacks, et al.Arteriosclerosis (Dallas, Tex.)|November 1, 1986
Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemiaW V Brown, C A Dujovne, J W Farquhar, et al.The American Journal of Clinical Nutrition|March 1, 1983
A double-blind, placebo-controlled study of sucrose polyester in hypercholesterolemic outpatientsM J Mellies, R J Jandacek, J D Taulbee, et al.The American Journal of Medicine|November 27, 1987
Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemiaR H Knopp, W V Brown, C A Dujovne, et al.Pageof 4